1. Home
  2. IMMP vs ESEA Comparison

IMMP vs ESEA Comparison

Compare IMMP & ESEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • ESEA
  • Stock Information
  • Founded
  • IMMP 1987
  • ESEA 2005
  • Country
  • IMMP Australia
  • ESEA Greece
  • Employees
  • IMMP N/A
  • ESEA N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • ESEA Marine Transportation
  • Sector
  • IMMP Health Care
  • ESEA Consumer Discretionary
  • Exchange
  • IMMP Nasdaq
  • ESEA Nasdaq
  • Market Cap
  • IMMP 211.1M
  • ESEA 208.2M
  • IPO Year
  • IMMP N/A
  • ESEA 2006
  • Fundamental
  • Price
  • IMMP $1.50
  • ESEA $28.96
  • Analyst Decision
  • IMMP Buy
  • ESEA Buy
  • Analyst Count
  • IMMP 2
  • ESEA 1
  • Target Price
  • IMMP $8.50
  • ESEA $53.00
  • AVG Volume (30 Days)
  • IMMP 84.6K
  • ESEA 29.5K
  • Earning Date
  • IMMP 05-02-2025
  • ESEA 05-22-2025
  • Dividend Yield
  • IMMP N/A
  • ESEA 8.97%
  • EPS Growth
  • IMMP N/A
  • ESEA N/A
  • EPS
  • IMMP N/A
  • ESEA 16.20
  • Revenue
  • IMMP $3,019,249.00
  • ESEA $212,897,313.00
  • Revenue This Year
  • IMMP N/A
  • ESEA $4.83
  • Revenue Next Year
  • IMMP $20.28
  • ESEA $3.27
  • P/E Ratio
  • IMMP N/A
  • ESEA $1.81
  • Revenue Growth
  • IMMP 24.11
  • ESEA 12.43
  • 52 Week Low
  • IMMP $1.32
  • ESEA $26.30
  • 52 Week High
  • IMMP $3.34
  • ESEA $50.92
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 39.93
  • ESEA 43.66
  • Support Level
  • IMMP $1.44
  • ESEA $28.52
  • Resistance Level
  • IMMP $1.56
  • ESEA $29.53
  • Average True Range (ATR)
  • IMMP 0.12
  • ESEA 1.46
  • MACD
  • IMMP 0.00
  • ESEA 0.11
  • Stochastic Oscillator
  • IMMP 41.63
  • ESEA 46.75

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About ESEA Euroseas Ltd. (Marshall Islands)

Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.

Share on Social Networks: